Alzheimer Disease
Conditions
Keywords
Alzheimer Disease, Alzheimer's
Brief summary
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Alzheimer's Disease patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Alzheimer's Disease patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patient is at least 50 to 80 years of age * Participant has a diagnosis of Alzheimer's Disease * Patient has self-identified as planning to enroll in an interventional clinical trial for Alzheimer's Disease
Exclusion criteria
* No diagnosis of Alzheimer's Disease confirmed * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a Alzheimer's Disease Clinical Trial | 3 months |
| Number of patients who remain in Alzheimer's Disease clinical trial until completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed